Jamie McCall

Chief Scientist

ExesaLibero Pharma, Inc.

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jamie McCall serves as Chief Scientist at ExesaLibero Pharma, Inc. in the United States. His research primarily focuses on the molecular regulation of bone turnover, particularly in the context of juvenile idiopathic arthritis and the effects of prenatal cadmium exposure. Recent articles authored by Dr. McCall include significant findings on targeting TRPC channels for controlling arthritis-induced bone erosion and the preclinical evaluation of ELP‐004 in mice.

Articles (5)

Year:

2025

Year:

2024

Year:

2024

Year:

Professor

Temple University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jamie McCall

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Targeting TRPC channels for control of arthritis-induced bone erosion

Preclinical evaluation of ELP‐004 in mice

Molecular Regulation of Bone Turnover in Juvenile Idiopathic Arthritis: Animal Models, Cellular Features and TNFα

Prenatal Cadmium Exposure Alters Proliferation in Mouse CD4<sup>+</sup> T Cells <i>via</i> LncRNA Snhg7.

Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.

Collaborators (5)

Michelle Witt

Peter Gannett

werner geldenhuys

Michael Zhu

Jonathan Soboloff

Make your next move.